Clinical Trial: A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection

U.S., May 24 -- ClinicalTrials.gov registry received information related to the study (NCT06987318) titled 'A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection' on April 25.

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, and efficacy of combination broadly neutralizing antibodies (bNAbs), to induce HIV-1 control during analytic treatment interruption (ATI).

Study Start Date: June 21

Study Type: INTERVENTIONAL

Condition: HIV-1-infection

Intervention: BIOLOGICAL: VRC07-523LS

Administered by Intravenous (IV) inf...